HOME >> BIOLOGY >> NEWS
Host response to anthrax lethal toxin suggests some current treatment strategies are inappropriate

Anthrax, a disease previously primarily relevant to the livestock-management community recently became a wordwide bioterrorism concern. However, human anthrax infection is primarily a result of direct or indirect contact with infected animals or exposure to contaminated animal products.

Bacillus anthracis, the causative agent of anthrax, is believed to induce disease and death in humans in an endotoxic shocklike manner. A comprehensive study of the effects of anthrax lethal toxin in mice by Stephen Leppla and colleagues at the National Institutes of Health demonstrated that toxin-induced death does not result from septic shock mediated by cytokine release as previously thought, but via hypoxia-induced liver failure. The study strongly suggests that the therapies developed for the treatment of cytokine-mediated septic shock will not be appropriate for the treatment of anthrax.

In an accompanying commentary, Alice Prince from Columbia University College of Physicians and Surgeons in New York states that "this analysis of the pathological effects of the B. anthracis lethal toxin should help focus future studies of optimal therapy for patients exposed to this organism. These results make clear that anthrax patients exhibit a unique pathophysiology and should not be considered to have generic shock analogous to Gram-negative sepsis". Prince continues "exactly how the lethal factor produces such profound tissue hypoxia, what metabolic processes are affected in the liver and elsewhere, and how these effects may be blocked will require further studies".


'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
2-Sep-2003


Page: 1

Related biology news :

1. Columbia research to examine gene influence on severity of peridontal disease, therapy response
2. Protective gene may enhance vaccine responses
3. Activated signaling pathway may predict lung cancer patients response to gefitinib
4. Duke study disputes idea that trees can relocate quickly in response to climate change
5. Researchers develop better understanding of immune response to viral infection
6. Molecular motor shuttles key protein in response to light
7. Triple-vaccine strategy stimulates strong HIV-specific immune response in monkeys
8. Genetic basis for individual variations in the response to stress
9. Drunken worms reveal a genetic basis of alcohol response
10. Researchers identify genetic markers to predict response to chemotherapy for colorectal cancer
11. With fat, women have a more visceral response

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/21/2020)... Virginia (PRWEB) , ... August 20, 2020 , ... ... today that Hassan Movahhed , a Clinical Operations executive with expertise in ... management, has joined the firm as an Expert Consultant. Throughout his career, Mr. ...
(Date:8/7/2020)... ... 06, 2020 , ... Nine middle school teachers from eight ... a unique professional development program that provides advanced STEM (science, technology, engineering and ... nationwide. , Created in partnership between the National Stem Cell Foundation and The ...
(Date:7/31/2020)... ... July 30, 2020 , ... ... therapeutics product portfolio with a near term focus on Type 2 diabetes and ... commercialization experience across multiple therapeutic areas and classes. As Chief Commercial Officer, Justin ...
Breaking Biology News(10 mins):
(Date:8/15/2020)... ... 2020 , ... Inc. magazine today revealed that Skysis is ... the nation’s fastest-growing private companies. The list represents a unique look at the ... Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their ...
(Date:8/7/2020)... WOODLANDS, Texas (PRWEB) , ... August 06, 2020 ... ... therapy and DNA vaccine industries, announces it has closed on the purchase of ... Technology Park in Conroe, TX and includes over 21 acres in the initial ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... launch of its new tagline, “BUILDING FOR LIFE.” The adoption of this taglines ... the globe, requiring fast track capacity to provide patients with urgently needed vaccines ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been ... webinar will cover the history of eSource, the reasons it did not take off ... wearables, to site source, the industry is moving towards capturing data electronically for clinical ...
Breaking Biology Technology:
Cached News: